Ticker
AKBACompany Name
AKEBIA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT per Share | Share Factor | Weighted Average Shares |
---|---|---|---|---|
6/30/2025 | $ -8.34M | $ -0.03 | 1 | 262.57M |
3/31/2025 | $ -21.86M | $ -0.09 | 1 | 235.5M |
12/31/2024 | $ -51.23M | $ -0.24 | 1 | 210.95M |
9/30/2024 | $ -33.27M | $ -0.16 | 1 | 210.35M |
6/30/2024 | $ -32.97M | $ -0.16 | 1 | 209.71M |
3/31/2024 | $ -36.06M | $ -0.18 | 1 | 204.96M |
12/31/2023 | $ -45.89M | $ -0.24 | 1 | 187.47M |
9/30/2023 | $ -54.84M | $ -0.29 | 1 | 188.31M |
6/30/2023 | $ -89.68M | $ -0.48 | 1 | 186.82M |
3/31/2023 | $ -44.17M | $ -0.24 | 1 | 184.77M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / (Shares WA * Share Factor)
(=) EBITPS
EBITPS for AKEBIA THERAPEUTICS INC is calculated as follows: EBIT [ $ -386.14M ] / (Shares WA [ 143.31M ] * Share Factor [ 1 ])
(=) EBITPS [ $ -2.69 ]
Minimum
Dec 31, 2020
Maximum
Jun 30, 2025
Average
Median
filtered constituents | 3.79K |
---|---|
min | $ -9.72 |
max | $ 10.76 |
average | $ 1.16 |
median | $ 0.39 |
std | $ 3.42 |